Navigation Links
Azathioprine to Treat Eczema?

About 20% of children suffer from atopic eczema, a disease which causes the skin to become very itchy and inflamed. Scientists are searching for new ways// to develop useful and powerful drug so it can more safely treat the most common form of eczema.

Azathioprine is a drug that was developed 40 years ago to prevent kidney transplant patients from rejecting their new organ. Its mechanism of action is by suppressing the immune system, but it results in increased side effects such as an increase their vulnerability to infection and suppress production of red and white blood cells.

A University of Newcastle team cut this risk. They did this by matching doses to levels of an enzyme in the blood that can break down the drug, so patients did not receive too much.

The study was funded by the British Skin Foundation. Researchers tested about 63 patients who had previously had a number of different treatments, including ultraviolet radiation therapy. Each was given a test to determine levels of an enzyme called TPMT in their blood.

The dose of Azathioprine they subsequently received was individually tailored to take account of this reading. Researcher Dr Simon Meggitt, a consultant dermatologist, said that by tailoring the drug researchers were able to minimize the risk of side effects without compromising its effectiveness.

What matters is the dose and if it is set right, the safety of the drug increases significantly. Margaret Cox, chief executive of the National Eczema Society, said that patients with Eczema go through hell everyday. The psychological impact can seriously affect confidence, self-esteem and quality of life.


Page: 1

Related medicine news :

1. Skin cancer linked to usage of Drug Azathioprine in organ transplants
2. Azathioprine Can Soon Revolutionize Eczema Treatment
3. Azathioprine 50mg Pills Recalled By FDA And Roxane Labs
4. Advances in Treatment of Cataracts
5. Recommendations for Treatment of Blood Pressue
6. New FDA Approved Drug To Treat Migraine
7. Treatment for Menieres disease
8. Treatment for pre-menstrual syndrome is ineffective
9. Angiotensin-II-receptor blockers - Treat kidney failure
10. Cipro Has Cheaper Cousins to Treat Anthrax
11. Better Treatment for obesity
Post Your Comments:

(Date:11/27/2015)... ... November 27, 2015 , ... ... Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group for end ... Microsoft Dynamics SL software users, partners, industry experts and representatives. Intellitec Solutions’ membership ...
(Date:11/27/2015)... ... November 27, 2015 , ... The moment ... itself for not only fulfilling the needs of advisers and clients but going ... price and providing top-tier customer service. However, there's always room for improvement, which ...
(Date:11/27/2015)... ... , ... CBD College is proud to announce that on November ... to its Diagnostic Medical Sonography program. CBD College is honored to join this very ... and universities in the state of California make the cut. CBD College is officially ...
(Date:11/27/2015)... ... November 27, 2015 , ... Dr. Thomas Dunlap and Dr. ... Tucker Bierbaum with Emergency Medicine at St., Joseph Health System’s Santa Rosa Memorial ... conditions present in similar ways and require time-critical intervention to avoid large area heart ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft ... announces the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite ... LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... Nov. 25, 2015  The American Academy of ... (ACOG), and the March of Dimes cheered today,s ... Our Infants Act of 2015 (S.799), which ... newborns born exposed to drugs, such as opioids, ... introduction, all three organizations have worked together leading ...
(Date:11/25/2015)... On Tuesday, November 24, 2015, the ... Wright Medical Technology, Inc. for product liability and ... implant device, awarded $11 million in favor of ... and three days of deliberations, the jury found ... designed and unreasonably dangerous, and that Wright Medical ...
(Date:11/25/2015)... , November 25, 2015 ... KTOV ) (TASE: KTOV), a biopharmaceutical company focused on ... of various clinical conditions, today announced the closing of ... Depository Shares ( ADSs ), each representing 20 ordinary ... to 3,158,900 ADSs. The ADSs and warrants were issued ...
Breaking Medicine Technology: